CN1554949A - 幽门螺杆菌尿素酶血清抗体快速诊断试剂盒及其制备方法 - Google Patents
幽门螺杆菌尿素酶血清抗体快速诊断试剂盒及其制备方法 Download PDFInfo
- Publication number
- CN1554949A CN1554949A CNA2003101224143A CN200310122414A CN1554949A CN 1554949 A CN1554949 A CN 1554949A CN A2003101224143 A CNA2003101224143 A CN A2003101224143A CN 200310122414 A CN200310122414 A CN 200310122414A CN 1554949 A CN1554949 A CN 1554949A
- Authority
- CN
- China
- Prior art keywords
- urease
- antigen
- kit
- bacterium
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010046334 Urease Proteins 0.000 title claims abstract description 41
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 20
- 210000002966 serum Anatomy 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 14
- 241000193830 Bacillus <bacterium> Species 0.000 title 1
- 239000000427 antigen Substances 0.000 claims abstract description 32
- 102000036639 antigens Human genes 0.000 claims abstract description 27
- 108091007433 antigens Proteins 0.000 claims abstract description 27
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000003745 diagnosis Methods 0.000 claims abstract description 5
- 238000003317 immunochromatography Methods 0.000 claims abstract description 3
- 241000894006 Bacteria Species 0.000 claims description 20
- 238000001514 detection method Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 11
- 229940037467 helicobacter pylori Drugs 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 241000590002 Helicobacter pylori Species 0.000 claims description 7
- 239000000084 colloidal system Substances 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000000020 Nitrocellulose Substances 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 229920001220 nitrocellulos Polymers 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 3
- 238000001262 western blot Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- 239000012528 membrane Substances 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 238000002523 gelfiltration Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 238000009007 Diagnostic Kit Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- DGZSVBBLLGZHSF-UHFFFAOYSA-N 4,4-diethylpiperidine Chemical compound CCC1(CC)CCNCC1 DGZSVBBLLGZHSF-UHFFFAOYSA-N 0.000 description 1
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical class C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101710145634 Antigen 1 Proteins 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- CQVDKGFMVXRRAI-UHFFFAOYSA-J Cl[Au](Cl)(Cl)Cl Chemical compound Cl[Au](Cl)(Cl)Cl CQVDKGFMVXRRAI-UHFFFAOYSA-J 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 108010088160 Staphylococcal Protein A Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101224143A CN100399026C (zh) | 2003-12-23 | 2003-12-23 | 幽门螺杆菌尿素酶血清抗体快速诊断试剂盒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101224143A CN100399026C (zh) | 2003-12-23 | 2003-12-23 | 幽门螺杆菌尿素酶血清抗体快速诊断试剂盒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1554949A true CN1554949A (zh) | 2004-12-15 |
CN100399026C CN100399026C (zh) | 2008-07-02 |
Family
ID=34338654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101224143A Expired - Fee Related CN100399026C (zh) | 2003-12-23 | 2003-12-23 | 幽门螺杆菌尿素酶血清抗体快速诊断试剂盒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100399026C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103293305A (zh) * | 2012-03-05 | 2013-09-11 | 美利泰格诊断试剂(嘉兴)有限公司 | 口腔螺旋杆菌感染检测方法及用于检测的唾液试板 |
CN107356755A (zh) * | 2017-07-25 | 2017-11-17 | 江斌 | 幽门螺杆菌抗体金检测试剂盒 |
CN111983229A (zh) * | 2020-09-07 | 2020-11-24 | 三门县人民医院 | 胶体金定量检测幽门螺杆菌抗体试剂条及检测方法 |
CN113341142A (zh) * | 2021-06-07 | 2021-09-03 | 北京捷乐生物科技有限公司 | 一种胃幽门螺杆菌抗体检测方法及试剂盒 |
CN115266286A (zh) * | 2022-07-29 | 2022-11-01 | 浙江欧赛思生物科技有限公司 | 一种新型髓鞘染色试剂盒及其染色方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102288757A (zh) * | 2011-07-12 | 2011-12-21 | 珠海市银科医学工程有限公司 | 无创伤一步法胃幽门螺旋杆菌检测试剂盒及检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837240A (en) * | 1995-04-28 | 1998-11-17 | Oravax-Merieux Co. | Multimeric, recombinant urease vaccine |
CN1140257A (zh) * | 1995-07-06 | 1997-01-15 | 中国预防医学科学院流行病学微生物学研究所 | 一种人血清抗幽门螺杆菌尿素酶抗体体外检测剂盒 |
CN1390949A (zh) * | 2002-06-25 | 2003-01-15 | 上海晶泰生物技术有限公司 | 一步多检的胶体金检测微生物的试剂盒 |
-
2003
- 2003-12-23 CN CNB2003101224143A patent/CN100399026C/zh not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103293305A (zh) * | 2012-03-05 | 2013-09-11 | 美利泰格诊断试剂(嘉兴)有限公司 | 口腔螺旋杆菌感染检测方法及用于检测的唾液试板 |
CN107356755A (zh) * | 2017-07-25 | 2017-11-17 | 江斌 | 幽门螺杆菌抗体金检测试剂盒 |
CN111983229A (zh) * | 2020-09-07 | 2020-11-24 | 三门县人民医院 | 胶体金定量检测幽门螺杆菌抗体试剂条及检测方法 |
WO2022048693A1 (zh) * | 2020-09-07 | 2022-03-10 | 三门县人民医院 | 胶体金定量检测幽门螺杆菌抗体试剂条及检测方法 |
CN113341142A (zh) * | 2021-06-07 | 2021-09-03 | 北京捷乐生物科技有限公司 | 一种胃幽门螺杆菌抗体检测方法及试剂盒 |
CN115266286A (zh) * | 2022-07-29 | 2022-11-01 | 浙江欧赛思生物科技有限公司 | 一种新型髓鞘染色试剂盒及其染色方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100399026C (zh) | 2008-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3202772B2 (ja) | ヘリコバクターピロリ検出用の抗原調製物 | |
CN111024954A (zh) | 联合检测covid-19抗原和抗体的胶体金免疫层析装置及其使用法 | |
EP0329570A2 (en) | Antigenic compositions containing fragments of Campylobacter pylori and methods for their production and use | |
US20160047807A1 (en) | Method for Detection of Legionella Bacteria Employing Purified Antigen-Specific Antibodies | |
CN111366728A (zh) | 一种用于检测新型冠状病毒SARS-CoV-2的免疫层析试剂盒 | |
CN101738473B (zh) | 梅毒螺旋体抗体诊断试剂盒及其制备方法 | |
EP2833147A1 (en) | Detection kit for influenza a virus | |
AU2010251237B2 (en) | Method for detecting a wound infection | |
WO2001044815A1 (en) | Helicobacter pylori antigens in blood | |
CN111562365B (zh) | 一种新型冠状病毒IgG/IgA抗体检测试剂盒 | |
CN1687134A (zh) | 幽门螺杆菌HpaA和ureB单克隆抗体、免疫测定法和诊断试剂盒 | |
CN100399026C (zh) | 幽门螺杆菌尿素酶血清抗体快速诊断试剂盒及其制备方法 | |
JP2779178B2 (ja) | 標的リガンド用アッセイの感度を高める方法 | |
JP2004500568A (ja) | 敗血症マーカーとしてのインター−アルファ−トリプシン | |
JP4268358B2 (ja) | 抗体および免疫学的測定方法 | |
CN1580772A (zh) | Sars病毒抗体双抗原夹心elisa检测法 | |
Mégraud | 5 Diagnosis of Helicobacter pylori | |
CA2134667C (en) | In vitro test for helicobacter pylori | |
CN112384805A (zh) | 一种检测新型冠状病毒的试剂盒和检测装置及其制备方法 | |
Robert et al. | Helicobacter pylori infection is not associated with an increased hemorrhagic risk in patients in the intensive care unit | |
CN1140257A (zh) | 一种人血清抗幽门螺杆菌尿素酶抗体体外检测剂盒 | |
CN105753982A (zh) | 抗人肺炎链球菌fam1家族PspA蛋白抗体及应用该抗体的免疫层析试剂盒 | |
WO2015093439A1 (ja) | ヘリコバクター・ピロリの検出方法 | |
CN105801692B (zh) | 抗3型解脲支原体mb蛋白抗体及应用该抗体的免疫层析试剂盒 | |
RU2127883C1 (ru) | Способ экспресс-диагностики дифтерийной инфекции |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHENZHEN CITY KANGMEI BIOLOGICAL TECHNOLOGY CO.,LT Free format text: FORMER NAME OR ADDRESS: SHENZHEN KANG MEI INDUSTRIAL DEVELOPMENT CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: Guangdong province Shenzhen City Futian District No. 178 Huarong Building mintian Road, room 1808 Patentee after: Shenzhen Kangmei biological science and Technology Co.,Ltd. Address before: 6013, Shennan Road, Futian District, Guangdong, Shenzhen City, Shenzhen Kang Mei Industrial Development Co., Ltd. Patentee before: KANGMEI INDUSTRY DEV Co.,Ltd. SH |
|
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN KANG MEI BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHENZHEN CITY KANGMEI BIOLOGICAL TECHNOLOGY CO.,LTD. Effective date: 20080919 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080919 Address after: Guangdong province Shenzhen City Futian District No. 178 Huarong Building mintian Road, room 1807 Patentee after: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Address before: Guangdong province Shenzhen City Futian District No. 178 Huarong Building mintian Road, room 1808 Patentee before: Shenzhen Kangmei biological science and Technology Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: Guangdong city of Shenzhen province Futian District Che Kung Temple Tian An Innovation and Technology Square, a A seat 1006B Patentee after: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Address before: Guangdong province Shenzhen City Futian District No. 178 Huarong Building mintian Road, room 1807 Patentee before: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: BEIJING KANGMEI TIANHONG BIOTECHNOLOGY Co.,Ltd. Assignor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Contract record no.: 2010440020211 Denomination of invention: Quick aiagnostic reagent kid for pyloric spiral bacillus urease serum antibody and its preparing method Granted publication date: 20080702 License type: Exclusive License Open date: 20041215 Record date: 20101109 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170303 Address after: 100095, Haidian District, Beijing high road, No. 1, building No. 16 Patentee after: BEIJING KANGMEI TIANHONG BIOTECHNOLOGY Co.,Ltd. Address before: 518040 Guangdong, Shenzhen, Che Kung Temple, Tian An Innovation Technology Plaza, phase A, block 1006-B, Patentee before: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: BEIJING KANGMEI TIANHONG BIOTECHNOLOGY Co.,Ltd. Assignor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Contract record no.: 2010440020211 Date of cancellation: 20210331 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Rapid diagnostic kit for Helicobacter pylori urease antibody and its preparation Effective date of registration: 20210430 Granted publication date: 20080702 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: BEIJING KANGMEI TIANHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021440020034 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230428 Granted publication date: 20080702 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: BEIJING KANGMEI TIANHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021440020034 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080702 |